Compare market size and growth of key Healthcare markets

Compare market size and growth of key Healthcare markets

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Loading...

Categories

11 Japan Diabetes Care Drugs Reports

Diabetes Care Drugs Market

Country Covered: Japan

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company

Japan Diabetes Drugs Industry

Country Covered: Japan

Study Period: 2018 - 2029

Major Players: Takeda, AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis

Japan Oral Anti-Diabetic Drug Market

Country Covered: Japan

Study Period: 2019 - 2029

Major Players: Sanofi, Eli Lilly and Company, Pfizer Inc., AstraZeneca, Johnson And Johnson

Diabetes Drug Market in Asia Pacific

Country Covered: Japan

Study Period: 2018 - 2029

Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis

Asia-Pacific Oral Anti-Diabetic Drug Market

Country Covered: Japan

Study Period: 2019 - 2029

Major Players: Sanofi, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., AstraZeneca

Anti Obesity Drugs Industry

Country Covered: Japan

Study Period: 2019 - 2029

Major Players: Vivus, F Hoffmann-La Roche AG, GlaxoSmithKline PLC, Novo Nordisk AS, Currax Pharmaceuticals LLC

Diabetic Foot Ulcer Treatment Market

Country Covered: Japan

Study Period: 2019 - 2029

Major Players: Convatec Inc., 3M, Integra LifeSciences, Coloplast Corp, Cardinal Health

Proliferative Diabetic Retinopathy Market

Country Covered: Japan

Study Period: 2019 - 2029

Major Players: Novartis AG, Regeneron Pharmaceuticals Inc, Allergan Plc, Hoffmann-La Roche (Genentech), Oxurion NV

Diabetes Combination Drugs Market

Country Covered: Japan

Study Period: 2019- 2029

Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S

Oral Antidiabetic Drugs Market

Country Covered: Japan

Study Period: 2018 - 2029

Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca

Hyperlipidemia Drugs Industry

Country Covered: Japan

Study Period: 2019 - 2029

Major Players: Merck & Co., Inc, Sanofi, Amgen, AstraZeneca, Viatris Inc.